Who makes PfAMA-1-FVO[25-545]?

PfAMA-1-FVO[25-545] is developed by European Vaccine Initiative.

What development phase is PfAMA-1-FVO[25-545] in?

PfAMA-1-FVO[25-545] is in Phase 1.

Last reviewed 2026-04-20 · How we verify

European Vaccine Initiative · Phase 1 active Biologic Quality 0/100

Generic name	PfAMA-1-FVO[25-545]
Sponsor	European Vaccine Initiative
Modality	Biologic
Phase	Phase 1

No approved indications tracked.

No common side effects on file.